Late relapse in patients with Graft-Versus-Host Disease (GVHD)

被引：0
|
作者：
Ferrant, A
Straetmans, N
Latinne, D
Van den Neste, E
Michaux, L
机构：
来源：
BONE MARROW TRANSPLANTATION | 2001年 / 27卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S172 / S173
页数：2
相关论文
共 50 条
  • [41] GRAFT-VERSUS-HOST DISEASE OR GRAFT-VERSUS-HOST LIKE SYNDROME
    BEYER, J
    SCHWERDTFEGER, R
    SIEGERT, W
    BLOOD, 1992, 80 (11) : 2948 - 2949
  • [42] IAPs Protect Host Target Tissues from Graft-Versus-Host Disease (GVHD)
    Toubai, Tomomi
    Rossi, Corinne
    Oravecz-Wilson, Katherine
    Zajac, Cynthia
    Fujiwawa, Hideaki
    Brabbs, Stuart
    Wu, Julia
    Sun, Yaping
    Magenau, John M.
    Reddy, Pavan R.
    BLOOD, 2016, 128 (22)
  • [43] Predictors of hematologic malignancy relapse in patients with advanced chronic graft-versus-host disease
    Claire L. Ruben
    Filip Pirsl
    Seth M. Steinberg
    Noa G. Holtzman
    Laura Parsons-Wandell
    Judy Baruffaldi
    Lauren M. Curtis
    Sandra A. Mitchell
    Ana Zelic Kerep
    Edward W. Cowen
    Ann Berger
    Galen O. Joe
    Manuel B. Datiles
    Jacqueline W. Mays
    Steven Z. Pavletic
    Bone Marrow Transplantation, 2021, 56 : 1584 - 1592
  • [44] Predictors of hematologic malignancy relapse in patients with advanced chronic graft-versus-host disease
    Ruben, Claire L.
    Pirsl, Filip
    Steinberg, Seth M.
    Holtzman, Noa G.
    Parsons-Wandell, Laura
    Baruffaldi, Judy
    Curtis, Lauren M.
    Mitchell, Sandra A.
    Kerep, Ana Zelic
    Cowen, Edward W.
    Berger, Ann
    Joe, Galen O.
    Datiles, Manuel B., III
    Mays, Jacqueline W.
    Pavletic, Steven Z.
    BONE MARROW TRANSPLANTATION, 2021, 56 (07) : 1584 - 1592
  • [45] Use of Ruxolitinib in Pediatric Patients with Steroid-Refractory Graft-versus-host Disease (GVHD)
    Becilli, Marco
    Merli, Pietro
    Pagliara, Daria
    Galaverna, Federica
    Algeri, Mattia
    Gaspari, Stefania
    Boccieri, Emilia
    Carta, Roberto
    Ruggeri, Annalisa
    Locatelli, Franco
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 631 - 631
  • [46] Graft-versus-Host Disease (GvHD) - an update. Part 2: Prognosis and therapy of GvHD
    Travnik, R.
    Beckers, M.
    Wolff, D.
    Holler, E.
    Landthaler, M.
    Karrer, S.
    HAUTARZT, 2011, 62 (03): : 229 - 237
  • [47] CYCLOSPORINE (CSA) VERSUS CYCLOPHOSPHAMIDE (CY) - PREVENTION OF GRAFT-VERSUS-HOST DISEASE (GVHD)
    SANTOS, GW
    BROOKMEYER, R
    SARAL, R
    TUTSCHKA, PJ
    EXPERIMENTAL HEMATOLOGY, 1985, 13 (05) : 427 - 427
  • [48] Cataract Prevalence and Cataract Surgery Outcomes in Patients with Ocular Graft-Versus-Host Disease (GVHD)
    Saboo, Ujwala
    Shikari, Hasanain
    Dana, Reza
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [49] Acute graft-versus-host disease (GVHD) overlapping chronic GVHD after reinduction chemotherapy
    Delgado-Jimenez, Y.
    Goiriz, R.
    Vargas-Diez, E.
    Fraga, J.
    Garcia-Diez, A.
    Fernandez-Herrera, J.
    BRITISH JOURNAL OF DERMATOLOGY, 2007, 156 (02) : 388 - 390
  • [50] Risk factors for the development of ocular graft-versus-host disease (GVHD) dry eye syndrome in patients with chronic GVHD
    Wang, Jay Ching Chieh
    Teichman, Joshua C.
    Mustafa, Majd
    O'Donnell, Heather
    Broady, Raewyn
    Yeung, Sonia N.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2015, 99 (11) : 1514 - 1518
12345